Cytochrome P450 pharmacogenetics as a predictor of toxicity and clinical response to pulse cyclophosphamide in lupus nephritis. [electronic resource]
Producer: 20040813Description: 2202-10 p. digitalISSN:- 0004-3591
- Adult
- Alleles
- Antirheumatic Agents -- administration & dosage
- Cohort Studies
- Cyclophosphamide -- administration & dosage
- Cytochrome P-450 Enzyme System -- genetics
- Female
- Gene Frequency
- Genetic Variation
- Genotype
- Homozygote
- Humans
- Kidney Failure, Chronic -- etiology
- Lupus Nephritis -- complications
- Male
- Middle Aged
- Polymorphism, Genetic
- Predictive Value of Tests
- Primary Ovarian Insufficiency -- chemically induced
- Pulse Therapy, Drug
- Retrospective Studies
- Risk Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.